Gore Medical has received FDA approval for the GORE C3 Delivery System for placement of the GORE EXCLUDER AAA Endoprosthesis. The unique advantage of the delivery system, according to the company, is the ability for the surgeon to reposition the stent graft to achieve a perfect permanent placement:
Once delivered into the aorta, the GORE C3 Delivery System uniquely and intuitively enables repositioning of the stent graft. The ability to reposition the device may minimize complications that could occur if the graft needs to be repositioned after the initial deployment.
According to Dr. Mark Fillinger, Professor of Surgery and Director, Vascular Surgery Training Programs at Dartmouth-Hitchcock Medical Center in Lebanon, NH, "The GORE C3 Delivery System is a significant technological advance for endovascular device deployment during treatment of aortic aneurysms. The technology gives physicians a second or even third opportunity to get the best possible deployment of the stent graft relative to the patient’s anatomy. This next generation delivery system has the potential to make endovascular repair easier in challenging anatomy."
Press release: Gore Receives FDA Approval for GORE C3 Delivery System for GORE EXCLUDER AAA Endoprosthesis…
Product page: GORE EXCLUDER AAA Endoprosthesis….